Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Curr Diabetes Rev. 2017;13(3):322–329. doi: 10.2174/1573399812666160427104157

Figure 3. Stage-specific clinical approaches to delay and prevent T1D progression.

Figure 3

The further the disease progresses the better we can make predictions of T1D development. However, preventive studies such antigen-specific therapies (AST) are more efficacious at earlier stages of T1D. Today, several clinical approaches already tested at T1D onset i.e. anti-CD3, are tested for prevention. Some of them are indicated in the figure.